Bridging the Gap: Conference Workbook [International Conference on AIDS (12th: 1994: Geneva, Switzerland)]

Monday, June29

OSTER SESSIONS Track A 11101-11125

Track A: Basic Science
11101 Generation of recombinant analogues of the C-C Chemokine rantes with
enhanced HIV-suppressive and reduced pro-inflammatory activity
Paolo Lusso*; Simona Polo; V Nardese; E. Prosperini; C. De Santis;
M. Rizzi; M. Bolognesi; P. Lusso, Italy
11102 AOP-RANTES inhibits CCR5 recycling - A novel inhibitory mechanism
of HIV-infectivity
Amanda E.I. Proudfoot*; M. Mack; D. Schlondorff; P. Clapham;
M. Marsh; T.N.C. Wells; M. Opperman, Switzerland, Germany, UK
11103 Modulation of HIV-1 Infection by CCR5 antagonists
Donald Mosier*; GR. Picchio; RJ. Gulizia; R. Sabbe; P. Poignard;
RE. Offord; J. Wilken; DA. Thompson; S. Kent, USA, Switzerland
11104 Anti-HIV chemokines: Domain mapping and HIV-2 lentivirus delivery
Suresh Arya*; M. Owais; A. Davis-Warren, USA
11105 Mechanism oftransdominant inhibition ofCCR5-mediated
HIV-1 infection by CCR5 D32
Kuan-Teh Jeang, USA
11106 Co-receptors and cellular targets for HIV-1 in the human female
genital tract
Florian Hladik*; G. Lentz; R.E. Akrioge; H. Kelly; McElroy;
Alef;McElrath, USA
11107 Bicyclams are selective antagonists of the chemokine receptor
CXCR4 and potent inhibitors of HIV
Dominique Schols*;J.A. Este; S. Struyf; J. van Damme; GJ. Bridger;
G. W Henson; E. de Clercg, Belgium
11108 Frequency of the D32 deletion allele of CCR5 coreceptor gene in HIVinfected and normal population of Central Europe
Bela Kemeny*; K nagy; A Horuath, Hungary
11109 Differential growth in Langerhans' cells between HIV-1 subtype B isolates.
Relation to route of transmission
Luis Enrique Soto-Ramirez*; B. Renjifo; G.M. Ruiz-Palacios;
M. Essex, Mexico
11110 Isolation of MIP-la-resistant macrophage-tropic HIV-1 selected
by passage in cell culture
Yosuke Maeda*; Yosuke Maeda; S.M. Matsushita; M.B.F. Foda;
K.N. Nanke; H.M. Maeda; S.H. Harada, Japan
11111 Study of co-receptors used by NSI HIV-1 strains that infect
CD4+ T cell lines, Molt4 and SupT1
Nathalie Dejucq*; Graham Simmonds; S. Hibbitts; P. Clapham, UK
11112 Tropism,characterization,and co-receptor usage of an HIV-1
isolate derived from HIV+ve person homozygous for CCR5D32
Hassan Naif*; M. Alali; S. Li; R. French; G. Stewart; A. Cunningham,
Australia
11113 Coreceptor use and MT2 tropism of HIV-1 chimeric clones
having envelope V3 loop of HIV-1 subtype E
Hironori Sato*; K.K. Kato; N.K. Kodaka; Y.T. Takebe, Japan
11114 The binding of HIV to permissive cells is coordinated by interactions
of gpl20 with both CD4 and V3 loop binding proteins
Christian Callebaut*; J. Blanco; B. Krust; N. Seddiki; S. Muller;
J.P. Briand; A.G. Hovanessian, France

11115 Coreceptor Utilization by Divergent Human Immunodeficiency
Viruses Involves A Highly Conserved Envelope Residue
Wei-Kung Wang*; T Dudek; YJ.Zhao; H.G. Brumblay; M. Essex;
TH. Lee, USA
11116 Tropism and co-receptor usage of tissue-derived HIV-1 primary
isolates obtained from patients at the terminal stage of disease
Hassan Naif*; Shan Li; M. Alali; N. Wasr; A. Cunningham, Australia
11117 A small molecule CXCR4 inhibitor that blocks
T cell line-tropic HIV-1 entry
Tsutomo Murakami*; Naoki Yamamoto; T. Murakami;
T. Nakajima; M. Waki; H. Tamamura; N. Fujii, Japan
11118 The common molecular determinants of HIV-1 tropism for
human colonic cells and astrocytes
J. Roberto Trujillo*; B. Meek; J.D. Brain, USA
11119 MIP-la, MIP-1b and RANTES b-chemokines increase the replication
ofT-tropic HIV strains through CXCR4 stimulation
Antonina Dolei*; Adriana Biolchini; C. Serra; S. Curreli; E. Gomes;
M. Ziccmeddu; F. Dianzi; A. Dolei, Italy
11120 Actin dependent dual receptor HIV-1 infection vs. single receptor
chemotaxis induction by HIV-1 envelope
David H. Schwartz*; Sujatha lyengar; J.E.K. Hildreth; J.B. Mitchell, USA
11121 Mutations in the Leucine Zipper-Like Heptad Repeat Sequence
of HIV-1 gp41 Dominantly Interferes with Wild-Type Virus Infectivity
Steve L. Chen*; S.F. Lee; HJ. Hao; L.K. Lauang, Taiwan
11122 The prevalence of the CCR5-delta32 gene deletion and CCR5 M303
mutation in South African populations
Carolyn Williamson*; B. Brice; T. Smit; R. Thomas; L. Louie;
C Quillent; E. van der Ryst, South Africa
11123 Prevalence of deletion in the b-chemokines receptores (CCR5 D32)
sequency codificator in blood donors in Sao Paulo, Brazil
Marcelo C. Silva*; M.A. Rossini; E.C. Sabino, Brazil
11124 Inhibition of HIV-1 reverse transcription by actinomycin D
(Act D): A potential approach for AIDS therapy
Judith G. Levin*; J. Guo; T. Wu;J. Bess; L.E. Henderson, USA
11125 Dominance of the E89G substitution in HIV-1 reverse transcriptase in
regard to increased polymerase processivity and patterns of pausing
Mark A. Wainberg*; Yudong Quan, Canada
NOTES

IUNE

CONFERENCE WORKBOOK

21